Skip to content

Spaced Education to Optimize Prostate Cancer Screening

Spaced Education to Optimize Prostate Cancer Screening

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01168323
Enrollment
95
Registered
2010-07-23
Start date
2007-01-31
Completion date
2009-02-28
Last updated
2010-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Medical Education, Educational Technology, Clinical Practice Guideline, Prostate specific antigen

Brief summary

Two memory research findings (the spacing and testing effects) can dramatically improve retention of learning, but they have largely have been ignored by educators. The researchers have developed a novel form of online education (termed 'spaced education') based on these two effects which has been shown in randomized trials to improve knowledge acquisition and boost learning retention. Using prostate cancer screening as an experimental system, the researchers investigated whether spaced education could durably improve clinicians' behaviors, not just their knowledge.

Interventions

Spaced education is currently delivered via periodic emails that contain clinical case scenarios and multiple-choice questions. Upon submitting answers to each question online, clinicians receive immediate feedback and educational material. The questions are then repeated over spaced intervals of time to harness the pedagogical benefits of the spacing effect.

Sponsors

US Department of Veterans Affairs
CollaboratorFED
Agency for Healthcare Research and Quality (AHRQ)
CollaboratorFED
American Urological Association
CollaboratorOTHER
Astellas Pharma US, Inc.
CollaboratorINDUSTRY
National Institutes of Health (NIH)
CollaboratorNIH
Wyeth is now a wholly owned subsidiary of Pfizer
CollaboratorINDUSTRY
Harvard University Faculty of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Primary care providers (physicians, nurse practitioners, and physician assistants) from the 8 Veterans Affairs (VA) hospitals in the New England region (Veterans Integrated Service Network 1 \[VISN-1\]) were eligible to enroll.

Exclusion criteria

* Primary care providers (PCPs) who ordered PSA as a screen for prostate cancer less than 10 times each year were excluded.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of inappropriate prostate-specific antigen (PSA) screening performed by cliniciansWeeks 1-108The primary outcome measure was the difference in the percentage of inappropriate PSA screening performed by clinicians in the spaced education and control cohorts. Based on published clinical guidelines and reports, inappropriate PSA utilization was defined as the use of PSA for prostate cancer screening in patients \>76 or \<40 years old, or with an estimated life expectancy of less than 10 years.

Secondary

MeasureTime frameDescription
Change in spaced education performance measured in weeks 1-36Weeks 1-36
Change in test scores between cohorts measured in weeks 1-36Weeks 1-36
Clinicians' intention to participate in future spaced education programsWeek 36Assessed on end-of program survey at week 36
Time required by clinicians to complete the spaced education questions-explanationsWeek 36Assessed on end-of program survey at week 36

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026